CytomX Therapeutics, Inc. (CTMX) Analyst Forecast

$0.63

north_east
$0.01 (1.88%)
Day's range
$0.59
Day's range
$0.63

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
11/08/2024 BMO Capital Etzer Darout $3.68 $1.09   237.61%
11/08/2024 Piper Sandler Joseph Catanzaro $3.25 $1.09   198.17%
08/09/2024 BMO Capital Etzer Darout $3.56 $1.18   201.69%
05/27/2024 Piper Sandler Joseph Catanzaro $3.50 $1.75   100%
05/09/2024 BMO Capital Etzer Darout $3.59 $4.19   -14.32%
05/09/2024 Wedbush Robert Driscoll $8.00 $2.40   233.46%
05/05/2024 Jefferies Roger Song $8.00 $4.46   79.57%
03/12/2024 Jefferies Roger Song $2.50 $2.15   16.28%
03/12/2024 BMO Capital Etzer Darout $3.25 $2.15   51.16%

CytomX Therapeutics, Inc. FAQ's

CytomX Therapeutics, Inc. has been rated by research analysts at BMO Capital, Piper Sandler, Wedbush, Jefferies in the past 90 days.